Biotech’s Dismal Performance

Biotech’s Dismal Bottom Line: More Than $40 Billion in Losses As Scientists Search for Cures, They Gobble Investor Cash; A Handful Hit the Jackpot ‘The Ultimate Roulette Game’ DAVID P. HAMILTON / Wall Street Journal 20 may 04 Sin […]

Nanotechnology, a hard pill to swallow whole

It is imperative to separate myth from reality in nanotechnology’s vision for medicine, to help decide how the technology can improve our lives without compromising our dignity and freedom. […]

GMOs — A Decade of Failure

The promises made by biotech companies have failed to become reality. […]

Metal Nanoshells, Cure or Curse?

Among the nanoparticles developed for use in medical and other applications are non-biodegradable metal nanoshells. Has enthusiasm to exploit their remarkable properties run too far ahead of safety considerations? […]

Why (nano) size matters

Industry and government regulators maintain that the unique size and properties of nanoscale materials do not warrant a closer look at the potential health, safety and environmental impacts. However, the ETC Group explains why size matters. […]

Nanotubes highly toxic

An entire molecular electronics industry is poised to take off, much of it on the back of carbon nanotubes. But new research found that nanotubes are highly damaging to the lungs of mice. […]

Nanotechnology, the wave of the future?

Nanotechnology has been touted as a ‘trillion-dollar industry’. However, before attempting to jump onto this bandwagon, developing countries must sift through the hype and consider potential hazards. […]

The Cartagena Biosafety Protocol and the WTO agreements (Chinese)

The relationship between the Cartagena Protocol on Biosafety and the WTO agreements has yet to be settled. The following article examines how the WTO agreements impact on biosafety and the Cartagena Protocol. […]

Submission to the WTO by academics

Submission of an amicus curiae to the WTO by a group of academics in relation to the case of “EC: Measures Affecting the Approval and Marketing of Biotech Products”. […]

Submission to the WTO by the Amicus Coalition

Submission of an amicus curiae by a group of NGOs to the WTO in relations to the case of “EC: Measures Affecting the Approval and Marketing of Biotech Products”. […]